bioMérieux: keeps afloat with broker upgrade

(CercleFinance.com) - The share of bioMérieux, a specialist of in vitro diagnosis, is just keeping its head above the water today (+0.
1% in early afternoon trading), with Berenberg upgrading the share from "sell" to "hold," while increasing its corresponding target price from 65 euros to 68 euros.

"While the bioMérieux story still carries some medium-term threats, near-term risk-reward is more balanced," the German broker says in its report.


Copyright (c) 2019 CercleFinance.com. All rights reserved.
The information and analyses distributed by Cercle Finance are only intended as decision-making support for investors. Cercle Finance's responsibility may not be entailed, either directly or indirectly following the use of such information and analyses by readers. Any non-professional investor is recommended to consult a professional advisor before making any investment decision. This indicative information in no way constitutes any invitation to sell or buy securities.